NCT06999369

Heart Failure Food Intervention Trial: Impact of a Guideline-based Nutrition Digital Tool in Heart Failure Patient Clinical Outcomes

Enrolling by Invitation
NAAges 18–89InterventionalHealth services
Sutter Health
~180 participants
Updated 2025-05-31 on ClinicalTrials.gov
What's tested:MedChef AppMedChefs and Instacart food voucher

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Blood Pressure
Measured over Baseline and 6 months
Heart Failure

NCT06999369

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • 2121 N. California Blvd., Suite 310

    Walnut Creek, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18-89 years old at time of enrollment
Any type of Heart failure diagnosis (e.g., I50.x) between 1/1/2023-present
Recent hospital admission (within a year)
Race/ethnicity: All race/ethnic groups
Location: patients have been treated in the Greater East Bay division and Greater Silicon Valley division areas.
Patients with have at least 1 office/outpatient visit with a primary care physician or cardiologist visit before index date

Exclusion

• Patients with certain patient history (cognitive disabilities) and end stage renal or metastatic cancer diagnosis
Patients with active drug/substance use. Patients with heart failure who have active substance use are excluded from the study. HF patients with substance use require additional monitoring and follow up due to potential severe withdrawal symptoms, acute HF exacerbation and drug overdose or medication errors. Standard protocol includes additional monitor vital signs (e.g., blood pressure, heart rate) and HF symptoms (e.g., edema, dyspnea), and performing regular laboratory tests (e.g., renal function, electrolytes) which is beyond the clinical and logistical capabilities of this study.
  • Blood PressureBaseline and 6 months

    Blood pleasure will be measure by mmHg